Richmond Estate Planner: Asurest Simplifies Estate Planning With Flat Fees and Mobile Services

Richmond Estate Planner: Asurest Simplifies Estate Planning With Flat Fees and Mobile Services
Richmond’s Asurest Estate Planning simplifies estate law with flat-fee mobile services, offering Wills, Trusts, and probate help, making legal planning accessible for Virginia families.

For many, estate planning can feel daunting, filled with complex legal terms, confusing processes, and unexpected costs. A trusted Richmond estate planner, Asurest Estate Planning, is changing that by offering straightforward estate planning at a flat rate. Known for its personalized estate and probate services, this Virginia-based mobile law firm meets clients wherever they are most comfortable.

Founded by attorney Matthew Reinaker, a graduate of the University of Richmond School of Law and Robins School of Business, Asurest Estate Planning specializes in helping individuals and families prepare essential documents, such as wills, trusts, medical directives, and Powers of Attorney.

With over 15 years of experience and more than 250 five-star reviews, Reinaker’s approach combines legal expertise with a client-first philosophy. His dual JD and MBA background allows him to bridge the gap between technical legal precision and practical, real-world financial planning.

Asurest Estate Planning guides families and individuals in creating a plan for their loved ones, preparing for all eventualities. The firm also assists in estate administration, which entails all the steps of going through probate and distributing assets fairly and equitably.

Unlike traditional law firms, Asurest Estate Planning eliminates the stress of hourly billing by offering flat-fee packages. Clients know the cost upfront, with no surprises. Additionally, the firm’s mobile model means meetings can take place in homes, via Zoom, or over the phone, removing barriers for busy professionals, young parents, and retirees alike.

“Estate planning doesn’t have to be overwhelming or inconvenient. Asurest was created to make the process easier, more accessible, and more personal. Whether meeting virtually, in clients’ homes, or alongside their financial advisors, the goal is to deliver solutions tailored to their needs,” said Reinaker.

A trusted estate planner serving the greater Richmond area, Asurest Estate Planning has built a reputation for demystifying estate law. With clients ranging from first-time planners to those updating legacy documents, this mobile estate planner ensures they all receive the same attentive, jargon-free guidance.

For more information, visit https://asurest.com.

For those managing an estate after a loved one’s passing, the firm offers probate services that provide step-by-step support, guiding executors through asset distribution and court procedures with clarity and efficiency. Backed by years of experience, Asurest empowers clients to secure their legacies with confidence.

A specialist in estate planning and business contract issues, Reinaker counsels clients regarding personal and professional legal matters, developing strategic plans and communicating legal alternatives and outcomes to individual and business clients.

“Every family’s situation is unique, and the focus is on listening first, then crafting a plan that aligns with their goals. My clients range from young parents and busy professionals to retirees focused on legacy planning. No matter their stage of life, I work to understand their goals and deliver clear, thoughtful solutions tailored to their needs,” said Reinaker.

Asurest Estate Planning is redefining estate planning and probate in Virginia by prioritizing accessibility, transparency, and personalized service. With flat-fee pricing, mobile consultations, and a client-first approach, the firm removes the stress and confusion often associated with the service. Combining legal precision with practical guidance, the firm ensures seamless estate planning and probate administration in Greater Virginia, empowering clients to protect their legacies with clarity and confidence.

About the Company:

Asurest Estate Planning is a Richmond-based mobile law firm specializing in personalized estate planning and probate services. Founded by attorney Matthew Reinaker, JD, MBA, the firm helps clients prepare wills, trusts, medical directives, and Powers of Attorney with transparent flat-fee pricing. Unlike traditional firms, Asurest meets clients at home or virtually, removing barriers for busy families, professionals, and retirees.

Media Contact
Company Name: Asurest Estate Planning
Contact Person: Matthew Reinaker
Email: Send Email
Phone: (804) 531-6149
Address:6610 Monument Avenue
City: Richmond
State: VA 23226
Country: United States
Website: https://asurest.com

Scalp Tech SMP Revolutionizes Hair Restoration with Cutting-Edge Training Programs

Scalp Tech SMP, a top hair loss and thinning solutions company in Fresno, CA, is changing lives with its state-of-the-art Scalp Micropigmentation (SMP) treatments. The organization is dedicated to improving clients’ confidence and giving aspiring professionals the skills they need to thrive in this quickly increasing area. They offer a permanent and natural-looking alternative to standard hair restoration treatments.

Scalp Micropigmentation is a new cosmetic technique that uses pigment to precisely make the scalp look like it has been shaved. This permanent “tattoo” is a good option for people who may not be good candidates for standard hair transplant surgery. Scalp Tech SMP uses the best procedures in the business, including sophisticated machines, high-quality pigments, and precise needles, to make a hair impression that looks just like stubble. The process is minimally invasive and doesn’t require any time off, which makes it easy and very satisfying for clients. A Scalp Tech SMP spokesperson said, “Scalp Micropigmentation is the only hair loss solution that works right away.”

SMP has many perks that appeal to a wide range of customers:

– For Men: Many men feel bad about themselves and are uncomfortable since they are losing their hair. SMP is a new way to make it look like they have more hair on their head. People with male-pattern baldness may find this option appealing because they can have a natural look or thicker coverage in certain areas.

– For Women Scalp Micropigmentation (SMP) is an excellent option for women experiencing thinning hair. It creates the illusion of denser hair by adding the appearance of tiny follicles to the scalp, reducing the contrast between hair and skin. This gives a fuller, more youthful look, boosts confidence, and offers a non-surgical, low-maintenance solution with immediate results.

– Hairline Restoration: SMP is a good option for people who want a long-term solution to have a natural-looking hairline without using powders, fibers, and other cosmetic concealers daily. Scalp Tech SMP can help restore hairlines, making them look younger and more confident.

– Density Enhancement: Scalp Tech SMP is a subtle and natural-looking way to enhance the density of hair that has thinned over time, making it look fuller and firmer.

– Scar Camouflage: Scalp Micropigmentation (SMP) is an effective solution for FUE and FUT hair transplant scars because it camouflages the scar tissue by replicating the look of natural hair follicles. This reduces the contrast between the scar and surrounding hair, making it far less noticeable. SMP also works on both thin and thick scars, is minimally invasive, and delivers immediate, long-lasting results without further surgery.

Scalp Micropigmentation (SMP) for beards is great for filling in patchy areas, defining edges, and creating the look of fuller facial hair. By replicating tiny hair follicles, it blends seamlessly with existing stubble or hair, giving a natural, sharp, and even appearance. It’s non-invasive, low-maintenance, and provides instant, lasting results without daily grooming hassles.

Scalp Tech SMP puts accessibility first by offering financing for all of its services, including both procedure and training finance. The cost of SMP operations is based on the Norwood scale stage. Stage 1 (Norwood 2–3) costs between $1,200 and $2,000; Stage 2 (Norwood 4–5) costs between $2,000 and $2,800; and Stage 3 (Norwood 6–7) costs between $2,800 and $3,800. SMP sessions usually last two to three hours and cost between $2,500 and $3,500 on average. Customers have often praised the company’s cheap prices and willingness to work around their schedules.

Scalp Tech SMP offers a full 3-day training course in Scalp Micropigmentation for people who want to become practitioners. They also provide an SMP Apprenticeship Program. The training covers every part of the SMP process in great detail, giving students the knowledge and skills they need to succeed. This program aims to give new professionals the tools they need to build their prospective clients’ confidence through SMP.

Client reviews always praise the Scalp Tech SMP team’s professionalism and skill. People especially praise practitioner Alex for his ability to get SMP results that look natural, give great follow-up, and greatly enhance clients’ confidence. One happy customer said, “Alex has changed my life and given my confidence back. I can’t thank him enough for that.” Scalp Tech SMP is delighted to serve a wide area from its location in Fresno, California. These areas include Madera, Clovis, Visalia, Lemoore, Merced, Hanford, Selma, Sanger, Bakersfield, Modesto, San Luis Obispo, and Stockton.

People who are interested are highly encouraged to contact Scalp Tech SMP to set up a consultation and find out how the staff can assist them in achieving the best outcomes.

About Scalp Tech SMP:

Scalp Tech SMP is a top company that helps people with hair loss and thinning hair. They are dedicated to providing the best Scalp Micropigmentation and other specialized cosmetic treatments. The organization is based in Fresno, California, and its goal is to help clients regain their confidence and get results that seem natural with modern techniques and specialized care. Scalp Tech SMP also has full training programs to help the next generation of SMP experts, especially those who want to help people with illnesses like alopecia.

Media Contact
Company Name: Scalp Tech SMP
Contact Person: Alex Siyavong
Email: Send Email
Country: United States
Website: http://scalptechsmp.com/

Non-Cystic Fibrosis Bronchiectasis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Insmed Inc, AstraZeneca, Zambon, CSL Behring

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Non-Cystic Fibrosis Bronchiectasis pipeline constitutes 15+ key companies continuously working towards developing 15+ Non-Cystic Fibrosis Bronchiectasis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

 

The Non-Cystic Fibrosis Bronchiectasis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

 

Non-Cystic Fibrosis Bronchiectasis Pipeline Insight, 2025 report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Non-Cystic Fibrosis Bronchiectasis Market.

 

Some of the key takeaways from the Non-Cystic Fibrosis Bronchiectasis Pipeline Report:

  • Companies across the globe are diligently working toward developing novel Non-Cystic Fibrosis Bronchiectasis treatment therapies with a considerable amount of success over the years.

  • Non-Cystic Fibrosis Bronchiectasis companies working in the treatment market are NovaBiotics Ltd, Synspira Therapeutics, Parion Sciences, Chiesi Farmaceutic, CSL Behring, Haisco Pharmaceutical, SolAeroMed Inc., AstraZeneca, Zambon SpA, Boehringer Ingelheim, Armata Pharmaceuticals, Renovion, and others, are developing therapies for the Non-Cystic Fibrosis Bronchiectasis treatment

  • Emerging Non-Cystic Fibrosis Bronchiectasis therapies in the different phases of clinical trials are- NP339, Research Programme:NCFB, Research programme: mucolytic agents, CHF 6333, CSL787, HSK31858, S-1226, Benralizumab, Colistimethate sodium, BI 1291583, AP-PA02, ARINA-1, and others are expected to have a significant impact on the Non-Cystic Fibrosis Bronchiectasis market in the coming years.

  • In August 2025, The FDA has approved brensocatib (Brinsupri; Insmed) for treating non–cystic fibrosis bronchiectasis, making it the first therapy approved for this patient population and the first dipeptidyl peptidase 1 (DPP1) inhibitor authorized for a neutrophil-mediated disease. Brensocatib is an oral, small-molecule, reversible DPP1 inhibitor that works by blocking DPP1, thereby reducing the activation of neutrophil serine proteases—key contributors to inflammation and tissue damage in chronic lung conditions like bronchiectasis.

  • In February 2025, The FDA granted priority review to brensocatib, an investigational treatment for patients with non-cystic fibrosis bronchiectasis. Following acceptance of the new drug application, the target action date has been set for August 12, 2025. If approved, brensocatib would become the first and only authorized therapy for bronchiectasis and the first drug in the new dipeptidyl peptidase 1 class for treating neutrophil-mediated diseases.

  • In February 2025, Verona Pharma is a biopharmaceutical company dedicated to developing and bringing to market innovative treatments for chronic respiratory diseases with considerable unmet medical needs. Ohtuvayre™ (ensifentrine) is the company’s inaugural commercial product and represents the first inhaled therapy for COPD maintenance that uniquely combines bronchodilator and non-steroidal anti-inflammatory effects in a single molecule. Ensifentrine also shows potential for treating non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma, and other respiratory conditions.

  • In December 2024, Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a biotech firm focused on developing high-purity, pathogen-specific bacteriophage therapies for chronic pulmonary diseases and antibiotic-resistant infections, has reported encouraging topline results from its Phase 2 (“Tailwind”) trial. The study assesses AP-PA02, a novel inhaled multi-phage therapy aimed at treating chronic Pseudomonas aeruginosa infections in patients with non-cystic fibrosis bronchiectasis (NCFB).

  • In July 2024, Armata Pharmaceuticals has announced the completion of patient enrollment for its Phase II Tailwind clinical trial, which is assessing the efficacy of inhaled AP-PA02 in individuals with non-cystic fibrosis bronchiectasis (NCFB) and chronic Pseudomonas aeruginosa infection.

  • In May 2024, Insmed Incorporated announced encouraging topline results from the ASPEN study, a global Phase III randomized, double-blind, placebo-controlled trial assessing the efficacy, safety, and tolerability of brensocatib in patients with non-cystic fibrosis bronchiectasis.

  • In April 2024, 30 Technology announced that the European Medicines Agency (EMA) has authorized the Phase I/IIa NOPA study to evaluate the safety, tolerability, and effectiveness of nebulized Nitric Oxide Formulations in patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) who have Pseudomonas aeruginosa or other potentially pathogenic microorganisms (PPMs).

 

Non-Cystic Fibrosis Bronchiectasis Overview

Non-Cystic Fibrosis Bronchiectasis is a chronic lung condition where the airways (bronchi) become permanently widened and damaged, leading to mucus buildup, inflammation, and recurrent infections. Unlike cystic fibrosis-related bronchiectasis, this form occurs due to other causes such as previous lung infections, immune disorders, or autoimmune diseases. Common symptoms include persistent cough, excessive sputum production, breathlessness, and frequent respiratory infections. Treatment focuses on airway clearance, antibiotics for infections, and managing underlying conditions to improve lung function and quality of life.

 

Get a Free Sample PDF Report to know more about Non-Cystic Fibrosis Bronchiectasis Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/non-cystic-fibrosis-bronchiectasis-ncfb-pipeline-insight

 

Emerging Non-Cystic Fibrosis Bronchiectasis Drugs Under Different Phases of Clinical Development Include:

  • NP339: NovaBiotics Ltd

  • Research Programme:NCFB: Synspira Therapeutics

  • Research programme: mucolytic agents: Parion Sciences

  • CHF 6333: Chiesi Farmaceutic

  • CSL787: CSL Behring

  • HSK31858: Haisco Pharmaceutical

  • S-1226: SolAeroMed Inc.

  • Benralizumab: AstraZeneca

  • Colistimethate sodium: Zambon SpA

  • BI 1291583: Boehringer Ingelheim

  • AP-PA02: Armata Pharmaceuticals

  • ARINA-1: Renovion

 

Non-Cystic Fibrosis Bronchiectasis Route of Administration

Non-Cystic Fibrosis Bronchiectasis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

  • Intravenous

  • Subcutaneous

  • Oral

  • Intramuscular

 

Non-Cystic Fibrosis Bronchiectasis Molecule Type

Non-Cystic Fibrosis Bronchiectasis Products have been categorized under various Molecule types, such as

  • Monoclonal antibody

  • Small molecule

  • Peptide

 

Non-Cystic Fibrosis Bronchiectasis Pipeline Therapeutics Assessment

  • Non-Cystic Fibrosis Bronchiectasis Assessment by Product Type

  • Non-Cystic Fibrosis Bronchiectasis By Stage and Product Type

  • Non-Cystic Fibrosis Bronchiectasis Assessment by Route of Administration

  • Non-Cystic Fibrosis Bronchiectasis By Stage and Route of Administration

  • Non-Cystic Fibrosis Bronchiectasis Assessment by Molecule Type

  • Non-Cystic Fibrosis Bronchiectasis by Stage and Molecule Type

 

DelveInsight’s Non-Cystic Fibrosis Bronchiectasis Report covers around 15+ products under different phases of clinical development like

  • Late-stage products (Phase III)

  • Mid-stage products (Phase II)

  • Early-stage product (Phase I)

  • Pre-clinical and Discovery stage candidates

  • Discontinued & Inactive candidates

  • Route of Administration

 

Further Non-Cystic Fibrosis Bronchiectasis product details are provided in the report. Download the Non-Cystic Fibrosis Bronchiectasis pipeline report to learn more about the emerging Non-Cystic Fibrosis Bronchiectasis therapies

 

Some of the key companies in the Non-Cystic Fibrosis Bronchiectasis Therapeutics Market include:

Key companies developing therapies for Non-Cystic Fibrosis Bronchiectasis are – Insmed Incorporated, AstraZeneca, Zambon, CSL Behring, Chiesi Farmaceutici, Haisco Pharmaceutical, Boehringer Ingelheim, Armata Pharmaceuticals, Renovion, SolAeroMed, and others.

 

Non-Cystic Fibrosis Bronchiectasis Pipeline Analysis:

The Non-Cystic Fibrosis Bronchiectasis pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Non-Cystic Fibrosis Bronchiectasis with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Non-Cystic Fibrosis Bronchiectasis Treatment.

  • Non-Cystic Fibrosis Bronchiectasis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Non-Cystic Fibrosis Bronchiectasis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Non-Cystic Fibrosis Bronchiectasis market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

 

Download Sample PDF Report to know more about Non-Cystic Fibrosis Bronchiectasis drugs and therapies

 

Non-Cystic Fibrosis Bronchiectasis Pipeline Market Drivers

  • Recent Developments to Improve Research into Bronchiectasis, emergence of Novel Drugs & Therapies with Great Market Potential are some of the important factors that are fueling the Non-Cystic Fibrosis Bronchiectasis Market.

 

Non-Cystic Fibrosis Bronchiectasis Pipeline Market Barriers

  • However, challenges Associated with the Drug Delivery, regulatory & Economic Hindrance and other factors are creating obstacles in the Non-Cystic Fibrosis Bronchiectasis Market growth.

 

Scope of Non-Cystic Fibrosis Bronchiectasis Pipeline Drug Insight

  • Coverage: Global

  • Key Non-Cystic Fibrosis Bronchiectasis Companies: NovaBiotics Ltd, Synspira Therapeutics, Parion Sciences, Chiesi Farmaceutic, CSL Behring, Haisco Pharmaceutical, SolAeroMed Inc., AstraZeneca, Zambon SpA, Boehringer Ingelheim, Armata Pharmaceuticals, Renovion, and others

  • Key Non-Cystic Fibrosis Bronchiectasis Therapies: NP339, Research Programme:NCFB, Research programme: mucolytic agents, CHF 6333, CSL787, HSK31858, S-1226, Benralizumab, Colistimethate sodium, BI 1291583, AP-PA02, ARINA-1, and others

  • Non-Cystic Fibrosis Bronchiectasis Therapeutic Assessment: Non-Cystic Fibrosis Bronchiectasis current marketed and Non-Cystic Fibrosis Bronchiectasis emerging therapies

  • Non-Cystic Fibrosis Bronchiectasis Market Dynamics: Non-Cystic Fibrosis Bronchiectasis market drivers and Non-Cystic Fibrosis Bronchiectasis market barriers

 

Request for Sample PDF Report for Non-Cystic Fibrosis Bronchiectasis Pipeline Assessment and clinical trials

 

Table of Contents

1. Non-Cystic Fibrosis Bronchiectasis Report Introduction

2. Non-Cystic Fibrosis Bronchiectasis Executive Summary

3. Non-Cystic Fibrosis Bronchiectasis Overview

4. Non-Cystic Fibrosis Bronchiectasis- Analytical Perspective In-depth Commercial Assessment

5. Non-Cystic Fibrosis Bronchiectasis Pipeline Therapeutics

6. Non-Cystic Fibrosis Bronchiectasis Late Stage Products (Phase II/III)

7. Non-Cystic Fibrosis Bronchiectasis Mid Stage Products (Phase II)

8. Non-Cystic Fibrosis Bronchiectasis Early Stage Products (Phase I)

9. Non-Cystic Fibrosis Bronchiectasis Preclinical Stage Products

10. Non-Cystic Fibrosis Bronchiectasis Therapeutics Assessment

11. Non-Cystic Fibrosis Bronchiectasis Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Non-Cystic Fibrosis Bronchiectasis Key Companies

14. Non-Cystic Fibrosis Bronchiectasis Key Products

15. Non-Cystic Fibrosis Bronchiectasis Unmet Needs

16 . Non-Cystic Fibrosis Bronchiectasis Market Drivers and Barriers

17. Non-Cystic Fibrosis Bronchiectasis Future Perspectives and Conclusion

18. Non-Cystic Fibrosis Bronchiectasis Analyst Views

19. Appendix

20. About DelveInsight

 

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Non-Cystic Fibrosis Bronchiectasis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Insmed Inc, AstraZeneca, Zambon, CSL Behring

Innormax Lands on the 2025 Inc. 5000 List, Ranking No. 813 Among America’s Fastest-Growing Private Companies

Innormax Lands on the 2025 Inc. 5000 List, Ranking No. 813 Among America's Fastest-Growing Private Companies

Innormax, a leading provider of Enterprise Resource Planning (ERP) solutions, is proud to announce its ranking at No. 813 on the 2025 Inc. 5000 list. The annual list, compiled by Inc. magazine, recognizes the fastest-growing private companies in the United States. This achievement places Innormax in the top 20% of all companies recognized. Such an honor is a testament to Innormax’s rapid growth, unwavering dedication to client success, and commitment to delivering innovative business solutions that drive efficiency and profitability.

The recognition comes during a period of significant change in the global business landscape, where technology adoption and operational agility are more critical than ever. By earning a place on the list, Innormax demonstrates that it is not only keeping pace with these changes but also leading the way in delivering transformative ERP solutions.

In just four years since its founding, Innormax has earned a place among the nation’s most successful businesses. The Inc. 5000 list is widely regarded as one of the most respected benchmarks for entrepreneurial success. Companies are ranked based on their percentage of revenue growth over a three-year period. Innormax’s ranking reflects its dedication to helping businesses maximize efficiency and scalability through expert implementation, support, and optimization of SAP software—particularly SAP Business One.

“We are incredibly honored to be named to the Inc. 5000 list,” said Ernest Orosco, Innormax’s Director of Sales. “This recognition is not just a number; it’s a direct result of the relentless hard work and passion of our entire team. It’s also a powerful affirmation of our dedication to our clients. We believe that by partnering with businesses and helping them implement smarter technology and best-in-class practices, we can unlock their growth potential. This accolade motivates us to push even further, innovate more, and continue our mission of empowering businesses to achieve their operational and financial goals.”

The 2025 Inc. 5000 list offers a unique look at the most successful companies within the economy’s most dynamic segment—independent, entrepreneurial businesses. Innormax is proud to stand among this elite group, reinforcing its position as an industry leader and trusted partner for businesses nationwide. The company looks forward to building on this momentum, continuing to innovate, and helping more clients achieve resilience and profitability in a competitive global marketplace.

About Innormax

Founded in 2021, Innormax is a certified SAP Partner specializing in comprehensive ERP solutions. The company is committed to enhancing the resilience and profitability of its clients through a full suite of services, including system implementation, user training, and ongoing support. Innormax’s core mission is to empower businesses across diverse industries, including pharma & biotech, contract manufacturing, omnichannel distribution, food and beverage, fashion, healthcare, and financial services. By combining deep industry expertise with cutting-edge ERP technology, Innormax helps organizations turn operational challenges into competitive advantages.

For more information, please visit innormax.com.

Media Contact
Company Name: Innormax
Email: Send Email
Phone: (619) 241-4100 466
Address:4660 La Jolla Village Dr, Suite 100
City: San Diego
State: CA 92122
Country: United States
Website: https://innormax.com/

USA Self Defense Centers Expands Into Outdoor and Camping Gear Market, Meeting Growing Demand for Survival and Self-Reliance Products

USA Self Defense Centers Expands Into Outdoor and Camping Gear Market, Meeting Growing Demand for Survival and Self-Reliance Products

USA Self Defense Centers, a recognized authority in non-lethal home defense solutions, is proud to announce a strategic expansion into the outdoor and camping gear space. Traditionally known for its commitment to home safety through alarm systems and self-defense tools like Byrna Launchers, the company now offers a curated line of camping gear, survival equipment, and solar-powered generators—designed to serve consumers seeking reliability, preparedness, and peace of mind beyond their front doors.

This new direction stems from a growing demand among USA Self Defense Centers’ customers for survival-oriented products that extend beyond home protection. The brand’s evolution reflects the modern consumer’s desire for self-reliance, not only in personal safety but also in outdoor, off-grid, and emergency settings.

Founder and owner Christopher Joseph shared the rationale behind this exciting shift:

“Over the past year, we noticed a trend—many of our visitors who came for home defense solutions were also searching for survival gear. As we moved to include survival tools and emergency readiness items, those same customers began showing strong interest in camping products as well,” said Joseph.

“It became clear to us that today’s consumer doesn’t draw a hard line between home defense and outdoor preparedness. They want versatile gear that works both in an urban emergency and out in the wilderness. That’s why we’re proud to offer practical, dependable camping equipment like weatherproof tents, solar-powered generators, and other field-tested gear for every environment. We’re not changing who we are—we’re expanding what we offer to meet the real-world needs of our community.”

— Christopher Joseph, Owner, USA Self Defense Centers

The newly launched outdoor category includes products such as:

  • All-season camping tents designed for quick setup and high durability

  • Compact solar-powered generators ideal for both weekend camping and emergency power outages

  • Portable water filtration systems for clean drinking water anywhere

  • Survival tools and emergency kits including fire starters, multi-tools, and first aid supplies

USA Self Defense Centers’ approach emphasizes quality, accessibility, and readiness. Each product undergoes rigorous evaluation for durability, ease of use, and real-world reliability before being added to the catalog.

This expansion also reinforces the organization’s mission to provide peace of mind through preparedness—whether that means protecting one’s home, camping in the wilderness, or being ready for the unexpected. The brand’s hybrid identity now bridges the gap between urban safety and outdoor self-sufficiency, offering something valuable to homeowners, survivalists, campers, and preppers alike.

Consumers can explore the new outdoor and survival gear collection now at www.usaselfdefensecenters.com.

Media Contact
Company Name: USA Self Defense Systems
Phone: (713) 701-7489, toll free (888) 231-3154
Address:Richmond Ave Suite A1B
City: Houston
State: TX 77056
Country: United States
Website: https://usaselfdefensecenters.com/

Worm Human Enters New Era Under Fresh Leadership: From Workplace Resource Hub to Consumer Advocacy Authority

Worm Human Enters New Era Under Fresh Leadership: From Workplace Resource Hub to Consumer Advocacy Authority

Worm Human, once a niche website serving HR professionals and employee resource managers, is undergoing a dynamic transformation. Under new ownership, the site is shedding its traditional identity and embracing a bold new purpose: empowering everyday consumers through fair, balanced, and insightful product and service reviews.

Long known for offering guidance on human resource management and workplace well-being, Worm Human is now repositioning itself as a trusted voice in consumer affairs. With a growing team of researchers, writers, and category specialists, the revamped platform is committed to uncovering the truth behind trending products and services—no fluff, no favoritism.

In its newly defined role, Worm Human will focus on detailed assessments of high-interest consumer products across industries like wellness, nutrition, financial services, and lifestyle. Recent reviews include market movers such as Cellucare (a popular skincare supplement), MCT Wellness (a health-boosting medium-chain triglyceride formula), and Birch Gold (a leading provider of precious metals investment services).

This pivot is being spearheaded by new owner and editorial director Emily Hartford, who brings both journalistic integrity and consumer passion to the role.

“Consumers are constantly bombarded with clever marketing, influencer promotions, and heavily biased content—often without a clear sense of what’s real and what’s reliable,” said Hartford.

“When I acquired Worm Human, I saw a chance to build something refreshingly different. We’re not here to be the loudest voice in the room—we’re here to be the most trustworthy. That means in-depth product testing, honest breakdowns of pros and cons, and a strong commitment to transparency. If something doesn’t live up to its claims, we’ll say so. If it does, we’ll explain why. Either way, readers walk away smarter.”

“This isn’t just a rebrand; it’s a reinvention of what consumer guidance can and should look like. I want Worm Human to be a place where people feel informed, not sold to. We aim to be the reader’s ally in a digital world that too often prioritizes profit over truth.”

— Emily Hartford, Owner and Editorial Director, Worm Human

The rebranded site will feature weekly editorial content, side-by-side product comparisons, category rankings, and educational guides. In addition, plans are in motion to introduce a “Worm Human Verified” badge—an editorial certification awarded only to products that meet rigorous testing and value benchmarks.

This move comes at a time when consumers are increasingly wary of misinformation and hidden sponsorships in online reviews. Worm Human intends to set a new standard in the space by keeping its review process clear, consistent, and rooted in actual user benefit.

The newly launched consumer platform is now live and accessible at www.wormhuman.com. Readers are encouraged to explore the latest reviews and subscribe for upcoming features, including deep dives into health trends, investment products, and lifestyle innovations.

Media Contact
Company Name: Worm Human
Email: Send Email
Address:1011 S Pearl Expy #107
City: Dallas
State: TX 75201
Country: United States
Website: https://wormhuman.com

Best Pool Builder SEO Agency: Pool Pros Marketing Named #1 Pool Marketing Agency

Best Pool Builder SEO Agency: Pool Pros Marketing Named #1 Pool Marketing Agency

Best Pool Builder SEO Agency
Pool Pros Marketing (poolpros.io) has been officially named the #1 Pool Marketing Agency for 2025, earning recognition as the Best Pool Builder SEO Agency in the nation. The award, highlighted by Tidewater News, follows a comprehensive review of marketing firms serving the pool and spa industry.

Pool Pros Marketing stood out for its proven expertise in SEO for pool builders, consistently helping contractors dominate Google rankings with data-driven strategies. Unlike many agencies that focus on short-term tactics, Pool Pros prioritizes long-term growth by marketing client-owned assets—including their websites and Google Business Profiles, ensuring that every dollar invested builds lasting value.

The firm’s credibility is further underscored by its founder, Scott Keever, an internationally recognized SEO expert and online reputation management strategist ranked among the top 1% of SEOs worldwide. Under his leadership, Pool Pros Marketing has developed a reputation for transparency, exclusivity, and unmatched results. The agency partners with only one pool company per city, giving clients dedicated focus and eliminating conflicts of interest.

Beyond SEO, Pool Pros Marketing offers comprehensive digital solutions that span the full funnel, including Google Ads, Local Services Ads (LSA), and Social Media Advertising, delivering strategies that drive both organic and paid growth. Their results-driven model has helped hundreds of pool builders nationwide move away from outdated agencies and toward sustainable success.

About Pool Pros Marketing

Pool Pros Marketing is the nation’s top-rated marketing agency for pool builders, specializing in SEO, Google Ads, Local Services Ads, and social media campaigns. With a client-first philosophy, exclusive partnerships, and elite digital expertise, Pool Pros helps pool companies achieve long-term growth through owned digital assets. Learn more at poolpros.io.

About Tidewater News

Tidewater News is a respected media outlet known for in-depth industry reporting, business rankings, and expert evaluations. Their recognition of Pool Pros Marketing followed a rigorous vetting process that included reviewing client results, interviewing pool builders, analyzing online reputation, and comparing strategic approaches. Pool Pros’ dedication to client-owned growth and measurable performance placed them firmly at the top of the rankings.

About Scott Keever

Scott Keever is the founder of Pool Pros Marketing and Keever SEO, where he has established himself as one of the world’s top SEO experts. With over 15 years of experience in digital marketing and reputation management, Scott has earned recognition as an entrepreneur, industry leader, and member of the Forbes Agency Council. His proven ability to deliver Page 1 rankings and his commitment to helping businesses grow through owned digital assets have positioned him as a trusted partner for pool companies nationwide.

Media Contact
Company Name: Tide Water Latest News
Contact Person: John Lancing
Email: Send Email
Phone: 7575178676
Address:301 Homestead Rd
City: Franklin
State: Virginia
Country: United States
Website: https://www.tidewaternews.com/business/best-pool-builder-marketing-agency-top-companies-for-pool-industry

660,000 B2B Users and Counting: Getint Expands Global Footprint in Enterprise Integrations

Getint reaches 660,000 B2B users worldwide, including 16 Fortune 500 companies, integrating leading Work Management & Collaboration Platforms and cementing its role as a trusted leader in secure, cross-platform integrations for enterprises and ITSM teams.

Getint, a trusted provider of secure integration and migration solutions for enterprises and IT teams, today announced it has surpassed 660,000 B2B users worldwide, including 16 Fortune 500 companies, and more than 6,000 active installations. This marks a major milestone in the company’s growth and reinforces its position as one of the fastest-growing Jira integration platforms, achieving over nearly 100% year-over-year growth.

Operating in the expanding Global Integration Platform as a Service (iPaaS) market—valued at USD 12.87 billion in 2024 and projected to reach USD 15.63 billion by 2025—Getint helps organizations connect and synchronize data effortlessly across leading tools, from Jira and ServiceNow to Azure DevOps, GitLab, Monday.com, and Salesforce.

In the past 12 months, Getint has:

– Published 50+ in-depth case studies and launched video interviews with global enterprise customers after one year of using and renewing the platform.

– Expanded integrations to include Git Repository alongside Work Management & Collaboration Platforms.

– Completed SOC 2 Type II auditing, ensuring compliance with the highest data protection standards.

– Achieved ISO 27001 and ISO 27018 certifications, underscoring its enterprise-grade security.

– Partnered with industry leaders including Atlassian (Gold Marketplace Partner), Microsoft, and Monday.com to provide certified migration and integration services.

Jacek Wizmur-Szymczak, Co-Founder of Getint, commented:

“Cross-platform integration is no longer a nice-to-have—it’s mission-critical for enterprises navigating multiple tools, distributed teams, and constant change. Surpassing 660,000 users is a testament to the trust our clients place in us.

We’re proud to deliver solutions that not only solve technical challenges but also help teams work as one, no matter where they are or what systems they use.”

Looking ahead, Getint is investing heavily in research, product development, and customer success to meet the evolving needs of its global user base. The company is currently working on AI innovations designed to align with the highest industry standards, as reflected in Gartner’s Magic Quadrant for Integration Platform as a Service, alongside leading global players such as Workato, Mulesoft, Zapier, and others.

For more information about Getint’s solutions, visit www.getint.io.

About Getint

Getint is a global provider of secure, reliable integration and migration solutions for enterprises, ITSM teams, and organizations operating across multiple platforms. With over 6,000 active installations and 660,000+ users worldwide, Getint enables seamless connections between tools like Jira, ServiceNow, Azure DevOps, GitLab, Monday.com, and more—ensuring teams work as one, regardless of the systems they use.

Certified in ISO 27001 and ISO 27018, GDPR compliant, and SOC 2 Type II audited, Getint delivers enterprise-grade security and performance trusted by industry leaders.

Media Contact
Company Name: Getint.io
Contact Person: Renata Hryniewicz
Email: Send Email
Country: Poland
Website: http://www.getint.io/

Premium Clean Sets New Standard for Professional Carpet Cleaning Services Across London

A family-run professional cleaning company announced the enhancement of its specialised carpet cleaning services for residential and commercial clients throughout all London boroughs. With a renewed focus on utilising advanced, eco-friendly cleaning technologies and certified expertise, the company is solidifying its position as a trusted leader in the city’s competitive cleaning industry.

Operating from its base at 10 Filmer Road, SW6 7BW, Premium Clean distinguishes itself through a commitment to quality and customer satisfaction. The company’s technicians are fully trained and insured, holding Prochem National Training Academy certifications. This specialised training ensures they can proficiently maintain all carpet types, from common synthetic fibres to delicate natural materials like wool and sisal, using industry-approved hot water extraction methods.

Premium Clean’s process is built on a foundation of meticulous care, beginning with a thorough analysis of carpet fibres to determine the most effective and safe cleaning approach. The service employs powerful Prochem and Ashbys extraction machines, capable of cleaning with steam up to 120 degrees to remove deep-seated dirt, bacteria, and allergens effectively. In line with growing consumer demand for sustainable practices, the company offers eco-friendly and non-toxic cleaning solutions that are safe for households with children and pets.

To meet diverse client needs, Premium Clean provides both Regular and Premium service tiers, detailing options for pre-treatment, stain removal, and deodorising. This transparent approach extends to their pricing and booking system, ensuring clarity for customers from the initial quote to the final inspection. The company stands behind its work with a 100% satisfaction guarantee, offering a complimentary re-cleaning if results do not meet client expectations. By combining rigorous professional standards with the flexibility of a family-run business operating six days a week, Premium Clean provides reliable, high-quality cleaning solutions across London.

About Premium Clean:

Premium Clean is a London-based cleaning services company specialising in carpet, upholstery, and end-of-tenancy cleaning. As a family-run business, it is dedicated to delivering professional, reliable, and affordable services to both domestic and commercial customers.

Media Contact
Company Name: Premium Clean
Contact Person: Kiril Natov
Email: Send Email
Country: United Kingdom
Website: https://premiumclean.co.uk/carpet-cleaning-london/

Legalese Decoder Expands With New Editorial Submission Service – Empowering Writers to Publish Plain-Language Legal Content and Niche Expertise for a Global Audience

Legalese Decoder Expands With New Editorial Submission Service - Empowering Writers to Publish Plain-Language Legal Content and Niche Expertise for a Global Audience

Legalese Decoder Expands With New Editorial Submission Service – Empowering Writers to Publish Plain-Language Legal Content and Niche Expertise for a Global Audience
Legalese Decoder, the AI-powered platform known for transforming complex legal language into clear, plain English, is proud to announce the launch of its Editorial Submission Service — a fast, affordable, and professional way for writers, journalists, agencies, and industry experts to publish authoritative, plain-language content in almost any niche.

Vancouver, Canada – Legalese Decoder, the AI-powered platform known for transforming complex legal language into clear, plain English, is proud to announce the launch of its Editorial Submission Service — a fast, affordable, and professional way for writers, journalists, agencies, and industry experts to publish authoritative, plain-language content in almost any niche.

This new contributor program welcomes all topics and industries that align with Legalese Decoder’s mission to make knowledge accessible — from business, finance, real estate, technology, healthcare, and education to lifestyle, travel, sustainability, and emerging markets. The only exclusions are adult and gambling-related content.

Making Legal and Niche Knowledge Accessible to All

Legalese Decoder was built on a single mission: break down barriers to understanding — whether those barriers are legal jargon or industry-specific complexity.

Through the new Editorial Submission Service, contributors can:

  • Publish Expert Legal or Industry Insights – Share tips, guides, and case studies relevant to your field.
  • Translate Complexity into Clarity – From legal contracts to niche regulations, explain them in language anyone can understand.
  • Reach a Global Audience – Legalese Decoder’s platform is read by individuals, businesses, educators, and journalists worldwide.
  • Build Professional Authority – Get published on a trusted, AI-optimized platform that blends technology with expert human review.

Streamlined Process for Contributors

The process is built for speed, transparency, and search visibility:

  1. Submit Your Article Online – Upload your draft at legalesedecoder.com/editorial-request.
  2. Pay a Nominal Review Fee – $20 per article covers editorial review, formatting, and optimization.
  3. Editorial Review – Content is reviewed for clarity, accuracy, and quality, ensuring it aligns with the platform’s standards.
  4. Fast Publication – Approved content goes live within two business days, often faster.

Open to Nearly All Niches

Legalese Decoder encourages contributions from a wide range of industries, including:

  • Law & Compliance – Contracts, rights, regulations, and case studies
  • Business & Finance – Strategy, investment, entrepreneurship, and fintech
  • Technology – AI, cybersecurity, blockchain, SaaS, and emerging tech
  • Real Estate – Property law, housing trends, and investment strategies
  • Healthcare & Wellness – Policy, patient rights, and regulatory updates
  • Education – Policy changes, academic resources, and learning tools
  • Lifestyle & Travel – Cultural insights, consumer rights abroad, and industry tips
  • Sustainability – Environmental law, green business, and ethical practices

Media Contact
Company Name: Legalese Decoder
Contact Person: William Tsui
Email: Send Email
Phone: (619) 975-3425
Country: Canada
Website: https://legalesedecoder.com